ClinicalTrials.gg
Status unknownNCT05703061Updated Nov 15, 2023

Sleep in Adolescents - Pilot Study

An interventional study of 10-hour Time in Bed in Sleep, sponsored by Rutgers, The State University of New Jersey. Status unknown at 1 site in United States. Open to participants aged 14 Years to 17 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2023-11-15.

Sponsored by Rutgers, The State University of New Jersey · Not applicable, Interventional, and Other

The sponsor has not verified this record recently (last verified Nov 2023), so the status shown — last known as Recruiting — may be out of date.
Phase
Not applicable
Study type
Interventional
Enrollment
30
Allocation
Randomized
Ages
14 Years to 17 Years
Sex
All
01

Study summary

The goal of this pilot clinical trial is to determine the feasibility and acceptability of increasing time in bed to 10 hours per night in children aged 14-17 years. The main question it aims to answer are:

  • How much additional sleep short-sleeping-adolescents (\~7h TIB/night) will obtain when asked to increase time-in-bed to 10h/night for seven consecutive nights compared to those who are not asked to increase time-in-bed?
  • Are adolescents able to comply with study demands: wearing two devices (one on wrist and one on hip) and completing daily sleep diaries and call-ins for seven days?
  • By acquiring participant feedback, how feasible and acceptable is it to increase time in bed for sleep to 10h/night using a questionnaire and semi-structured interview?
  • Complete a phone screen
  • Come to Rutgers Sleep Lab for an orientation to obtain equipment, answer questionnaires and study staff will obtain consent
  • Wear a wrist device and a hip device for one week to observe sleep and physical activity
  • If assigned to the 10 hour time-in-bed group, they will follow specific procedures to ensure protocol adherence
  • Come to the Rutgers Sleep Lab for a follow up to give back equipment and answer questionnaires

Researchers will compare the control group to the 10 hour time in bed group to see if it is feasible for 14-17 year olds to be in bed for that long and wear two devices.

Read the detailed description

We are conducting this research study to determine if it is feasible to have teenagers devote more time to being in bed for sleep. Specifically, we will try to determine how much more teens sleep when spending 10 hours in bed for a week. If after it is determined from a phone screen that the child is eligible, they will be asked to come into our Center for an Orientation.

During this visit, we will explain the research study to participants and families in more detail. Families that enroll will visit the Center one more time at the end of the study. During the orientation visit, we will determine the child's final eligibility based on how much he/she sleeps and a measurement of the child's height and weight. If eligible and interested in participating, the child would wear two devices -one that measures sleep and one that measures activity - and keep a sleep diary for a week. During this week, the child would also call/text our Center twice each day to report on his/her bedtime and wake time. The second visit to the center occurs at the end of that week.

02

Conditions studied

  • Sleep
03

In context

Lead sponsor

Rutgers, The State University of New Jersey is the lead sponsor of 504 studies on the registry; 131 are open to participants now.

Of its 39 completed or terminated interventional studies of FDA-regulated products, 31 (79%) have results posted.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
14 Years to 17 Years
Sexes eligible
All
Accepts healthy volunteers
Yes

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Parent-reported child age of 14-17 years
  • Typical sleep duration of approximately 7hr/night on school nights
  • BMI for age and gender in the >5th percentile but not greater than 100% overweight.
  • Parent must be the primary caretaker and at home during bed/wake times
  • Reported willingness and ability to complete all study-related tasks, including wearing the wrist actigraph and hip accelerometer daily.

Exclusion criteria

Exclusion Criteria:

  • Diagnosable sleep disorder (including Sleep Disordered Breathing) based on parent report and participant's score on Sleep Disorders Inventory for Students-Adolescents (SDIS-A).
  • Medication use or parent-reported diagnosis of a serious medical condition (including psychiatric conditions) that may impact sleep.
  • Excessive intake of caffeine (>300mg/day), drug (including nicotine) or alcohol use, or a history of substance abuse.
  • Actively trying to lose weight.
  • Trans-meridian (east-west/west-east) travel during past month or planned travel during study time frame.
  • Inability to understand or complete protocol to ensure that consent/assent and reliable and valid measures are obtained.
  • Sibling of enrolled subjects, to minimize risk of bias in study findings.
05

Study design

Phase
Not applicable
Primary purpose
Other
Allocation
Randomized
Intervention model
Parallel assignment
Masking
None (open label)
Enrollment
30 participants (estimated)

Study arms

  • No intervention
    Normal Sleep Condition Group

    This group will not partake in the intervention, they will sleep the normal amount that they do on a regular basis. Participants will wear a hip physical activity monitor and a wrist actigraph to measure sleep.

  • Experimental
    10-hour Time in Bed Group

    This group will partake in the intervention of increasing time in bed to 10 hours per night. Participants will wear a hip physical activity monitor and a wrist actigraph to measure sleep.

    Behavioral: 10-hour Time in Bed

Interventions

  • Behavioral10-hour Time in Bed

    Participants will be asked to increase their time in bed to 10-hours per night for 7 consecutive days.

06

What researchers measure

Primary outcomes

  1. Feasibility and Acceptability of Increasing Time in Bed to 10 hours per Night in Adolescents

    An acceptability and feasibility questionnaire will be administered to participants at a follow up visit to measure the difficulty of increasing time in bed to 10 hours per night and wearing the two devices given. This questionnaire serves as feedback for the principal investigator to measure the feasibility of adolescents increasing time in bed to 10 hours per night and wearing two devices. Roughly half the questions are open ended and gauge the participants' physical experience during the study. The other half are scored 0-4 and ask about the participants' increase or decrease in school performance, overall mental health status, and physical health status during the day. For the questions that rank 0-4, a 0 indicates that specific aspect became a lot worse since the study, and a 4 indicates it became a lot better, or it increased over the course of the study.

    Time frame: The questionnaire will take approximately 5-10 minutes.

07

Study locations

1 of 1 sites recruiting
  • Rutgers Sleep Lab
    New Brunswick, New Jersey 08901, United States
    • Taylor McCoy, B.S. · Contact · tm953@kines.rutgers.edu · 732-554-1532
    • Andrea Spaeth, Ph.D · Principal investigator
    Recruiting
08

References and documents

Publications

  • Luginbuehl M B-KK, Ferron J, Anderson WM, Benbadis SR. Pediatric sleep disorders: Validation of the SleepDisorders Inventory for Students. . School Psychol Rev. 2008; 37(3):409-31.
  • Actigraph Data Collection, Proofing, and Scoring Procedures AW2 2018
  • Santos-Lozano A, Santin-Medeiros F, Cardon G, Torres-Luque G, Bailon R, Bergmeir C, Ruiz JR, Lucia A, Garatachea N. Actigraph GT3X: validation and determination of physical activity intensity cut points. Int J Sports Med. 2013 Nov;34(11):975-82. doi: 10.1055/s-0033-1337945. Epub 2013 May 22. PubMed 23700330 ↗

Study documents

  • Study protocol · Nov 4, 2022

Documents are hosted by the registry — open the source record to download them.

Individual participant data

Plan to share: Yes — All individual participant data that will be collected will be shared with other researchers, after deidentification.

Supporting information: Study protocol, Informed consent form

Time frame: Immediately following publication.

Access criteria: Anyone who wishes to access the data can do so.

09

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reached

Started Jul 2023 (actual). Primary completion is estimated for Jun 2024, 11 months after the start.

How these figures are worked out, and which studies are left out of them.

Registered
Jan 5, 2023
First posted
Jan 27, 2023
StartActual
Jul 1, 2023
Primary completionEst.
Jun 2024
CompletionEst.
Aug 2024
Last update
Nov 15, 2023
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Nov 15, 2023, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT05703061
Responsible party
Andrea M. Spaeth, PhD (Assistant Professor, Undergraduate Academic Director, Rutgers, The State University of New Jersey) — Principal investigator
First posted
Jan 27, 2023
Start date
Jul 1, 2023
Primary completion
Jun 2024 (estimated)
Completion
Aug 2024 (estimated)
Last update
Nov 15, 2023

Study contacts

Taylor McCoy, B.S.
Contact
tm953@kines.rutgers.edu
732-554-1532
Andrea Spaeth, Ph.D
principal investigator · Associate Professor, Lab Director

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is status unknown, as verified in Nov 2023. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion